Literature DB >> 18340462

Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol.

Melanie Fassbender1, Sylvia Herter, Rafaela Holtappels, Hansjörg Schild.   

Abstract

Dendritic cells (DCs) are the most powerful antigen presenting cells (APCs) in the immune system. Therefore, they are able to take up antigen by phagocytosis, macropinocytosis or endocytosis, process it in the cytosol and present it to naive T cells. It is known that presentation of the immunodominant influenza virus nucleoprotein-derived CTL epitope is delayed in bone marrow-derived DCs (BMDCs) compared to non-professional APCs. This delay coincided with the formation of transient aggregations of ubiquitinated proteins (DALIS, dendritic cell aggresome-like induced structures), which contain probably defective ribosomal products (DRiPs). DRiPs appear in the cytosol of maturing DCs and macrophages. Normally, DRiPs are degraded rapidly by proteasomes. However, their storage in DALIS delays their degradation. So, it is hypothesized that DALIS can function as antigen depots allowing DCs to coordinate maturation and antigen presentation during their migration to the lymph nodes. Upon inhibition of several pathways among the in signal transduction pathways of DCs, like the phosphatidylinositol 3-kinase (PI3-K) or the mammalian target of Rapamycin (mTOR), the cells show a rendered maturation profile. The formation of DALIS is inhibited in these cells which can be expected to influence antigen processing and presentation.

Entities:  

Mesh:

Year:  2008        PMID: 18340462     DOI: 10.1007/s00430-008-0091-4

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  21 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

2.  Transient aggregation of ubiquitinated proteins during dendritic cell maturation.

Authors:  Hugues Lelouard; Evelina Gatti; Fanny Cappello; Olivia Gresser; Voahirana Camosseto; Philippe Pierre
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

Review 3.  Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance.

Authors:  Matthias J Reddehase
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

Review 4.  To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins.

Authors:  Jonathan Yewdell
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

5.  Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice.

Authors:  Annalisa Del Prete; William Vermi; Erica Dander; Karel Otero; Laura Barberis; Walter Luini; Sergio Bernasconi; Marina Sironi; Amerigo Santoro; Cecilia Garlanda; Fabio Facchetti; Matthias P Wymann; Annunciata Vecchi; Emilio Hirsch; Alberto Mantovani; Silvano Sozzani
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

6.  Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells.

Authors:  Sylvia Herter; Philipp Osterloh; Norbert Hilf; Gerd Rechtsteiner; Jörg Höhfeld; Hans-Georg Rammensee; Hansjörg Schild
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

Review 7.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 8.  Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.

Authors:  S N Sehgal
Journal:  Clin Biochem       Date:  1998-07       Impact factor: 3.281

Review 9.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?

Authors:  J W Yewdell; L C Antón; J R Bennink
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

10.  Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus.

Authors:  Markus Wagner; Anja Gutermann; Jürgen Podlech; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  5 in total

Review 1.  Oncomodulation by human cytomegalovirus: evidence becomes stronger.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

Review 2.  Immunoregulatory functions of mTOR inhibition.

Authors:  Angus W Thomson; Hēth R Turnquist; Giorgio Raimondi
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

3.  The Hsc/Hsp70 co-chaperone network controls antigen aggregation and presentation during maturation of professional antigen presenting cells.

Authors:  Nadja Kettern; Christian Rogon; Andreas Limmer; Hansjörg Schild; Jörg Höhfeld
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

4.  PaCS is a novel cytoplasmic structure containing functional proteasome and inducible by cytokines/trophic factors.

Authors:  Patrizia Sommi; Vittorio Necchi; Agostina Vitali; Daniela Montagna; Ada De Luigi; Mario Salmona; Vittorio Ricci; Enrico Solcia
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

5.  PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NF‑κB in tumour metastases of colon carcinoma.

Authors:  Jie-Qiong Wang; Yi Tang; Qing-Shu Li; Ming Xiao; Ming Li; Yong-Tao Sheng; Yi Yang; Ya-Lan Wang
Journal:  Oncol Rep       Date:  2019-03-07       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.